
|Articles|February 18, 2022
Daily Medication Pearl: Vortioxetine (Trintellix)
Author(s)Saro Arakelians, PharmD
Vortioxetine (Trintellix) treats major depressive disorder in adults.
Advertisement
Medication Pearl of the Day: Vortioxetine (Trintellix)
Indication: Trintellix is indicated for the treatment of major depressive disorder in adults.
Insight:
- Dosing: The recommended starting dose is 10 mg administered orally once daily without regard to meals
- Dosage forms: Tablets 5 mg, 10 mg, and 20 mg.
- Adverse events: Most common adverse reactions (incidence ≥5% and at least twice the rate of placebo) were nausea, constipation, and vomiting.
- Mechanism of action: The mechanism of the antidepressant effect of vortioxetine is not fully understood, but is thought to be related to its enhancement of serotonergic activity in the CNS through inhibition of the reuptake of serotonin.
- Manufacturer: Takeda Pharma
Sources:
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
GLP-1 Receptor Agonists Show Promise Across Alcohol, Opioid, and Tobacco Use Disorders
2
UConn’s Medical Writing Certificate Program: It’s Just "Write"
3
TACTI-004 Trial Studying Eftilagimod Alfa With Pembrolizumab in Advanced NSCLC to Begin Evaluation
4
Pharmacy Policy Updates for October 2025
5